ClinicalTrials.gg
Drug

Leronlimab clinical trials

Also written PRO 140.

studies test it
25
open now
2
in phase 3
7
first study started
2004

How each study uses leronlimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the leronlimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Leronlimab
8
Leronlimab (700mg)
4
350 mg leronlimab
2
700 mg leronlimab
2
Humanized monoclonal antibody to CCR5
2

Development codes

PRO 140
18
PA14
1
WHO 10751
1

Studies by the year they started

24 studies that test it; most in 2020 (4); 1 more planned to start later

Studies that test leronlimab, by start year
YearStudies
20041
20071
20081
20121
20131
20143
20151
20162
20172
20181
20191
20204
20213
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
21
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 6

CytoDyn, Inc. (19) · Hospital Israelita Albert Einstein (2) · Drexel University (2) · City of Hope Medical Center (1) · Weill Medical College of Cornell University (1)

Often tested with

Tested in the same studies.

Floxuridine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test leronlimab.

Studies

Open first, then newest update. How each study uses leronlimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test leronlimab →

Codes

What other systems call leronlimab · ClinicalTrials.gg INT004303

  • MeSH (NLM) C420063leronlimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) Y1J4NP8FF0LERONLIMABConfirmed FDA, NLM
  • NCI Thesaurus C137824LeronlimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.